CPIX

Cumberland Pharmaceuticals (CPIX) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.

SEC Filings

Cumberland Will File Duchenne Heart Drug Without A Phase 3 Trial, Though The FDA Raised Doubts

The drugmaker plans to seek traditional approval of ifetroban using its Phase 2 study, after the agency questioned the data package.

SEC Filings

Cumberland's 41-Patient Ifetroban Trial In Scleroderma Backs Safety, Not Efficacy

The pilot study was not designed or powered to test whether the drug works, the company said, and most patients showed limited progression.